Researchers found that higher COVID-19 vaccination rates are linked to reduced asthma symptoms in children, highlighting broader health benefits of vaccination during the pandemic.
Vertex, Alpine’s IgAN drug has Humira-like potential. But not all indications are created equal
Will Vertex’s “pipeline-in-a-product” pay off? That’s the bet behind the company’s $4.9 billion acquisition of Alpine Immune Sciences and its mid-stage IgA nephropathy drug, which
April 20, 2024